In this comment letter, Arnold Ventures provides recommendations to address barriers and harness opportunities to advance generic drug repurposing research and policy.
In this comment letter, Arnold Ventures provides recommendations to address barriers and harness opportunities to advance generic drug repurposing research and policy.
